NCT04988282 Systemic Corticosteroids in Treatment of Post-COVID-19 Interstitial Lung Disease Status COMPLETED Phase PHASE4
NCT04946708 Virtual Exercise Program in Interstitial Lung Disease (ILD) Patients Status COMPLETED Phase NA
NCT04930289 Global Utilization And Registry Database for Improved preservAtion of doNor LUNGs Status ENROLLING_BY_INVITATION Phase N/A
NCT04928586 Immunosuppressant Combined With Pirfenidone in CTD-ILD Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT04925375 Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease Status RECRUITING Phase PHASE2
NCT04905693 Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease Status ENROLLING_BY_INVITATION Phase PHASE3
NCT04837131 A Study to Evaluate the Safety and Tolerability of Oral Ixazomib in Scleroderma-related Lung Disease Patients Status TERMINATED Phase PHASE2
NCT04813900 Correlation Between Lung UltraSound Score and Hypoxemia for Interstitial Syndrome in Emergency Department Status COMPLETED Phase NA
NCT04805086 The MONACO Cell Therapy Study: Monocytes as an Anti-fibrotic Treatment After COVID-19 Status UNKNOWN Phase PHASE1/PHASE2
NCT04803617 Investigation of Pectoralis Muscle Strength in Elderly With Interstitial Lung Disease Status COMPLETED Phase N/A
NCT04760548 Segmentation of Structural Abnormalities in Chronic Lung Diseases Status UNKNOWN Phase N/A
NCT04719078 Thorax MRI for Evaluation of Lung Morphology, Ventilation and Perfusion Status UNKNOWN Phase NA